Radiosurgical and Radiation Considerations for Residual, Recurrent and Malignant Spinal Cord Tumor

  • Jason WeaverEmail author


Radiation therapy has emerged as a viable option for the treatment of residual and recurrent intramedullary spinal cord tumors. Although the literature is limited owing largely to the low prevalence of primary spinal cord tumors, some evidence can be extrapolated from the treatment for residual and recurrent metastatic disease affecting the spinal cord. In this setting, radiation plays a crucial component in pain management, prevention of pathological fractures, and preventing neurological decline. The planning and implementation does necessitate a multidisciplinary team to develop a comprehensive strategy, which accounts for the complexity of metastatic disease to improve outcomes and minimize complication rates.


Radiation Therapy External Beam Radiation Therapy Stereotactic Radiosurgery Stereotactic Body Radiotherapy Intensity-Modulated Radiation Therapy Volumetric Modulated Arc Therapies 


  1. 1.
    Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg. 1980;53(6):741–8. Scholar
  2. 2.
    Marshall LF, Langfitt TW. Combined therapy for metastatic extradural tumors of the spine. Cancer. 1977;40(5):2067–70.PubMedCrossRefGoogle Scholar
  3. 3.
    Khan FR, Glicksman AS, Chu FC, Nickson JJ. Treatment by radiotherapy of spinal cord compression due to extradural metastases. Radiology. 1967;89(3):495–500. Scholar
  4. 4.
    Gerszten PC, Welch WC (2000) Current surgical management of metastatic spinal disease. Oncology 14 (7):1013-1024; discussion 1024, 1029-1030.Google Scholar
  5. 5.
    Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–8. Scholar
  6. 6.
    Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66(2):143–6.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW, Dutch Bone Metastasis Study G. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer. 2005;103(2):320–8. Scholar
  8. 8.
    Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine. 2001;26(3):298–306.PubMedCrossRefGoogle Scholar
  9. 9.
    Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Manzano G, Green BA, Vanni S, Levi AD. Contemporary management of adult intramedullary spinal tumors-pathology and neurological outcomes related to surgical resection. Spinal Cord. 2008;46(8):540–6. Scholar
  11. 11.
    Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery. 2005;56(5):972–81. discussion 972-981Google Scholar
  12. 12.
    Harrop JS, Ganju A, Groff M, Bilsky M. Primary intramedullary tumors of the spinal cord. Spine. 2009;34(22 Suppl):S69–77. Scholar
  13. 13.
    Samuel N, Tetreault L, Santaguida C, Nater A, Moayeri N, Massicotte EM, Fehlings MG. Clinical and pathological outcomes after resection of intramedullary spinal cord tumors: a single-institution case series. Neurosurg Focus. 2016;41(2):E8. Scholar
  14. 14.
    Parsa AT, Chi JH, Acosta FL Jr, Ames CP, McCormick PC. Intramedullary spinal cord tumors: molecular insights and surgical innovation. Clin Neurosurg. 2005;52:76–84.PubMedGoogle Scholar
  15. 15.
    Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, Kim KJ, Kim ES, Eoh W, Kim HJ. Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. Neuro-Oncology. 2013;15(7):921–9. Scholar
  16. 16.
    Safaee M, Oh MC, Mummaneni PV, Weinstein PR, Ames CP, Chou D, Berger MS, Parsa AT, Gupta N. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults. J Neurosurg Pediatr. 2014;13(4):393–9. Scholar
  17. 17.
    Tarapore PE, Modera P, Naujokas A, Oh MC, Amin B, Tihan T, Parsa AT, Ames CP, Chou D, Mummaneni PV, Weinstein PR. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients. Neurosurgery. 2013;73(2):247–55.; discussion 255. Scholar
  18. 18.
    Klekamp J. Spinal ependymomas. Part 1: Intramedullary ependymomas. Neurosurg Focus. 2015;39(2):E6. Scholar
  19. 19.
    Bostrom A, Kanther NC, Grote A, Bostrom J. Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience. BMC Res Notes. 2014;7:908. Scholar
  20. 20.
    Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V, Brown PD. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro-Oncology. 2013;15(4):406–12. Scholar
  21. 21.
    Minehan KJ, Shaw EG, Scheithauer BW, Davis DL, Onofrio BM. Spinal cord astrocytoma: pathological and treatment considerations. J Neurosurg. 1995;83(4):590–5. Scholar
  22. 22.
    Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, Mehta AI, Hardin C, Bagley CA, Isaacs RE, Haglund MM, Friedman AH. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurgery 76 Suppl 1:S4-13; discussion S13. 2015; Scholar
  23. 23.
    Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary spinal cord tumors: part II—management options and outcomes. Global Spine J. 2016;6(2):176–85. Scholar
  24. 24.
    Adams H, Avendano J, Raza SM, Gokaslan ZL, Jallo GI, Quinones-Hinojosa A. Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007. Spine. 2012;37(12):E727–35. Scholar
  25. 25.
    Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg. 1992;77(3):355–9. Scholar
  26. 26.
    Tovar Martin MI, Lopez Ramirez E, Saura Rojas E, Arregui Castillo G, Zurita Herrera M. Spinal cord astrocytoma: multidisciplinary experience. Clin Transl Oncol. 2011;13(3):185–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Lonser RR, Weil RJ, Wanebo JE, Devroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):106–16. Scholar
  28. 28.
    Richard S, Campello C, Taillandier L, Parker F, Resche F. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med. 1998;243(6):547–53.PubMedCrossRefGoogle Scholar
  29. 29.
    Rifkinson-Mann S, Wisoff JH, Epstein F. The association of hydrocephalus with intramedullary spinal cord tumors: a series of 25 patients. Neurosurgery. 1990;27(5):749–54. discussion 754PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Cinalli G, Sainte-Rose C, Lellouch-Tubiana A, Sebag G, Renier D, Pierre-Kahn A. Hydrocephalus associated with intramedullary low-grade glioma. Illustrative cases and review of the literature. J Neurosurg. 1995;83(3):480–5. Scholar
  31. 31.
    Mirone G, Cinalli G, Spennato P, Ruggiero C, Aliberti F. Hydrocephalus and spinal cord tumors: a review. Childs Nerv Syst. 2011;27(10):1741–9. Scholar
  32. 32.
    Samii M, Klekamp J. Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery. 1994;35(5):865–73. discussion 873CrossRefGoogle Scholar
  33. 33.
    Malis LI. Intramedullary spinal cord tumors. Clin Neurosurg. 1978;25:512–39.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Ferrante L, Mastronardi L, Celli P, Lunardi P, Acqui M, Fortuna A. Intramedullary spinal cord ependymomas--a study of 45 cases with long-term follow-up. Acta Neurochir. 1992;119(1–4):74–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Aghakhani N, David P, Parker F, Lacroix C, Benoudiba F, Tadie M. Intramedullary spinal ependymomas: analysis of a consecutive series of 82 adult cases with particular attention to patients with no preoperative neurological deficit. Neurosurgery. 2008;62(6):1279–85.; discussion 1285-1276. Scholar
  36. 36.
    Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, Group IMW. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–38. Scholar
  37. 37.
    Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study. Lancet. 2015;385(9974):1206–18. Scholar
  38. 38.
    Klekamp J, Samii M. Introduction of a score system for the clinical evaluation of patients with spinal processes. Acta Neurochir. 1993;123(3–4):221–3.PubMedGoogle Scholar
  39. 39.
    McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990;72(4):523–32. Scholar
  40. 40.
    Hall WA, Stapleford LJ, Hadjipanayis CG, Curran WJ, Crocker I, Shu HK. Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review. Int J Surg Oncol. 2011;2011:979214–9. Scholar
  41. 41.
    Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine. 2007;32(2):193–9. Scholar
  42. 42.
    Sung DI, Chang CH, Harisiadis L. Cerebellar hemangioblastomas. Cancer. 1982;49(3):553–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Smalley SR, Schomberg PJ, Earle JD, Laws ER Jr, Scheithauer BW, O'Fallon JR. Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int J Radiat Oncol Biol Phys. 1990;18(5):1165–71.PubMedCrossRefGoogle Scholar
  44. 44.
    Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, Desilvio M. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97(11):798–804. Scholar
  45. 45.
    Howell DD, James JL, Hartsell WF, Suntharalingam M, Machtay M, Suh JH, Demas WF, Sandler HM, Kachnic LA, Berk LB. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer. 2013;119(4):888–96. Scholar
  46. 46.
    Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, Wong R, Hahn C. Palliative radiation therapy for bone metastases: Update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4–12. Scholar
  47. 47.
    Maranzano E, Bellavita R, Rossi R, De Angelis V, Frattegiani A, Bagnoli R, Mignogna M, Beneventi S, Lupattelli M, Ponticelli P, Biti GP, Latini P. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol. 2005;23(15):3358–65. Scholar
  48. 48.
    Katagiri H, Takahashi M, Inagaki J, Kobayashi H, Sugiura H, Yamamura S, Iwata H. Clinical results of nonsurgical treatment for spinal metastases. Int J Radiat Oncol Biol Phys. 1998;42(5):1127–32.PubMedCrossRefGoogle Scholar
  49. 49.
    Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol. 2012;24(2):112–24. Scholar
  50. 50.
    Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25(11):1423–36. Scholar
  51. 51.
    Ryu SI, Chang SD, Kim DH, Murphy MJ, Le QT, Martin DP, Adler JR Jr. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49(4):838–46.PubMedGoogle Scholar
  52. 52.
    Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol. 1998;16(4):1613–24. Scholar
  53. 53.
    Faul CM, Flickinger JC. The use of radiation in the management of spinal metastases. J Neuro-Oncol. 1995;23(2):149–61.CrossRefGoogle Scholar
  54. 54.
    Myrehaug S, Sahgal A, Hayashi M, Levivier M, Ma L, Martinez R, Paddick I, Regis J, Ryu S, Slotman B, De Salles A. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine. 2017;27(4):428–35. Scholar
  55. 55.
    De Amorim BK, Delaney T. Chordomas and chondrosarcomas-The role of radiation therapy. J Surg Oncol. 2016;114(5):564–9. Scholar
  56. 56.
    Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant? Pract Radiat Oncol. 2015;5(6):e589–96. Scholar
  57. 57.
    Gerszten PC, Welch WC. Cyberknife radiosurgery for metastatic spine tumors. Neurosurg Clin N Am. 2004;15(4):491–501. Scholar
  58. 58.
    Gerszten PC, Burton SA, Welch WC, Brufsky AM, Lembersky BC, Ozhasoglu C, Vogel WJ. Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer. 2005;104(10):2244–54. Scholar
  59. 59.
    Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ, Welch WC, Baar J, Friedland DM. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2005;3(4):288–95. Scholar
  60. 60.
    Bilsky MH, Yamada Y, Yenice KM, Lovelock M, Hunt M, Gutin PH, Leibel SA. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report. Neurosurgery. 2004;54(4):823–30. discussion 830-821PubMedCrossRefGoogle Scholar
  61. 61.
    Benzil DL, Saboori M, Mogilner AY, Rocchio R, Moorthy CR. Safety and efficacy of stereotactic radiosurgery for tumors of the spine. J Neurosurg. 2004;101(Suppl 3):413–8. Scholar
  62. 62.
    Yamada Y, Katsoulakis E, Laufer I, Lovelock M, Barzilai O, McLaughlin LA, Zhang Z, Schmitt AM, Higginson DS, Lis E, Zelefsky MJ, Mechalakos J, Bilsky MH. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Neurosurg Focus. 2017;42(1):E6. Scholar
  63. 63.
    Joaquim AF, Ghizoni E, Tedeschi H, Pereira EB, Giacomini LA. Stereotactic radiosurgery for spinal metastases: a literature review. Einstein. 2013;11(2):247–55.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Chang JH, Shin JH, Yamada YJ, Mesfin A, Fehlings MG, Rhines LD, Sahgal A. Stereotactic Body Radiotherapy for Spinal Metastases: What are the Risks and How Do We Minimize Them? Spine. 2016;41(Suppl 20):S238–45. Scholar
  65. 65.
    Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, Weinberg JS, Brown BW, Wang XS, Woo SY, Cleeland C, Maor MH, Rhines LD. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7(2):151–60. Scholar
  66. 66.
    Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH. Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine. 2013;18(3):207–14. Scholar
  67. 67.
    Harel R, Emch T, Chao S, Elson P, Krishnaney A, Djemil T, Suh J, Angelov L. Quantitative Evaluation of Local Control and Wound Healing Following Surgery and Stereotactic Spine Radiosurgery for Spine Tumors. World Neurosurg. 2016;87:48–54. Scholar
  68. 68.
    Harel R, Pfeffer R, Levin D, Shekel E, Epstein D, Tsvang L, Ben Ayun M, Alezra D, Zach L. Spine radiosurgery: lessons learned from the first 100 treatment sessions. Neurosurg Focus. 2017;42(1):E3. Scholar
  69. 69.
    Zach L, Tsvang L, Alezra D, Ben Ayun M, Harel R. Volumetric Modulated Arc Therapy for Spine Radiosurgery: Superior Treatment Planning and Delivery Compared to Static Beam Intensity Modulated Radiotherapy. Biomed Res Int. 2016;2016:6805979–6. Scholar
  70. 70.
    Lovelock DM, Zhang Z, Jackson A, Keam J, Bekelman J, Bilsky M, Lis E, Yamada Y. Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases. Int J Radiat Oncol Biol Phys. 2010;77(4):1282–7. Scholar
  71. 71.
    Damast S, Wright J, Bilsky M, Hsu M, Zhang Z, Lovelock M, Cox B, Zatcky J, Yamada Y. Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases. Int J Radiat Oncol Biol Phys. 2011;81(3):819–26. Scholar
  72. 72.
    Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M, Mechalakos J, Zatcky J, Fuks Z, Yamada Y. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1744–8. Scholar
  73. 73.
    Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71(2):484–90. Scholar
  74. 74.
    Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S, Welch WC. CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery. 2004;55(1):89–98. discussion 98-89PubMedGoogle Scholar
  75. 75.
    Gerszten PC, Ozhasoglu C, Burton SA, Welch WC, Vogel WJ, Atkins BA, Kalnicki S. CyberKnife frameless single-fraction stereotactic radiosurgery for tumors of the sacrum. Neurosurg Focus. 2003;15(2):E7.PubMedGoogle Scholar
  76. 76.
    Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55(1):162–7.PubMedCrossRefGoogle Scholar
  77. 77.
    Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery. 1995;36(2):311–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Paton GR, Frangou E, Fourney DR. Contemporary treatment strategy for spinal metastasis: the "LMNOP" system. Canad J Neurol Sci. 2011;38(3):396–403.PubMedCrossRefGoogle Scholar
  79. 79.
    Laufer I, Rubin DG, Lis E, Cox BW, Stubblefield MD, Yamada Y, Bilsky MH. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–51. Scholar
  80. 80.
    Spratt DE, Beeler WH, de Moraes FY, Rhines LD, Gemmete JJ, Chaudhary N, Shultz DB, Smith SR, Berlin A, Dahele M, Slotman BJ, Younge KC, Bilsky M, Park P, Szerlip NJ. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol. 2017;18(12):e720–30. Scholar
  81. 81.
    Rades D, Abrahm JL. The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol. 2010;7(10):590–8. Scholar
  82. 82.
    Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine. 1990;15(1):1–4.PubMedCrossRefGoogle Scholar
  83. 83.
    Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn MJ, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten P, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlings MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A. Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. 2015;16(16):e595–603. Scholar
  84. 84.
    Sciubba DM, Petteys RJ, Dekutoski MB, Fisher CG, Fehlings MG, Ondra SL, Rhines LD, Gokaslan ZL. Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine. 2010;13(1):94–108. Scholar
  85. 85.
    Klekamp J, McCarty E, Spengler DM. Results of elective lumbar discectomy for patients involved in the workers' compensation system. J Spinal Disord. 1998;11(4):277–82.PubMedCrossRefGoogle Scholar
  86. 86.
    Huisman M, van den Bosch MA, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2012;84(1):8–14. Scholar
  87. 87.
    van der Linden YM, Lok JJ, Steenland E, Martijn H, van Houwelingen H, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004;59(2):528–37. Scholar
  88. 88.
    Foro Arnalot P, Fontanals AV, Galceran JC, Lynd F, Latiesas XS, de Dios NR, Castillejo AR, Bassols ML, Galan JL, Conejo IM, Lopez MA. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008;89(2):150–5. Scholar
  89. 89.
    Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J Neuro-Oncol. 2000;47(3):231–8.CrossRefGoogle Scholar
  90. 90.
    Sahgal A, Roberge D, Schellenberg D, Purdie TG, Swaminath A, Pantarotto J, Filion E, Gabos Z, Butler J, Letourneau D, Masucci GL, Mulroy L, Bezjak A, Dawson LA, Parliament M, The Canadian Association of Radiation Oncology-Stereotactic Body Radiotherapy Task Force. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol. 2012;24(9):629–39. Scholar
  91. 91.
    Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;88(5):1114–9. Scholar
  92. 92.
    Sahgal A, Ames C, Chou D, Ma L, Huang K, Xu W, Chin C, Weinberg V, Chuang C, Weinstein P, Larson DA. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys. 2009;74(3):723–31. Scholar
  93. 93.
    Thibault I, Campbell M, Tseng CL, Atenafu EG, Letourneau D, Yu E, Cho BC, Lee YK, Fehlings MG, Sahgal A. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases. Int J Radiat Oncol Biol Phys. 2015;93(2):353–60. Scholar
  94. 94.
    Nelson JW, Yoo DS, Sampson JH, Isaacs RE, Larrier NA, Marks LB, Yin FF, Wu QJ, Wang Z, Kirkpatrick JP. Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int J Radiat Oncol Biol Phys. 2009;73(5):1369–75. Scholar
  95. 95.
    Park HJ, Kim HJ, Won JH, Lee SC, Chang AR. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT? Technol Cancer Res Treat. 2015;14(2):159–67. Scholar
  96. 96.
    Husain ZA, Sahgal A, De Salles A, Funaro M, Glover J, Hayashi M, Hiraoka M, Levivier M, Ma L, Martinez-Alvarez R, Paddick JI, Regis J, Slotman BJ, Ryu S. Stereotactic body radiotherapy for de novo spinal metastases: systematic review. J Neurosurg Spine. 2017;27(3):295–302. Scholar
  97. 97.
    Moussazadeh N, Lis E, Katsoulakis E, Kahn S, Svoboda M, Distefano NM, McLaughlin L, Bilsky MH, Yamada Y, Laufer I. Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys. 2015;93(2):361–7. Scholar
  98. 98.
    Chang UK, Cho WI, Kim MS, Cho CK, Lee DH, Rhee CH. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol. 2012;51(5):589–95. Scholar
  99. 99.
    Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Brundage MD, Nabid A, Tissing-Tan CJ, Oei B, Babington S, Demas WF, Wilson CF, Meyer RM, Chen BE, Wong RK. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol. 2014;15(2):164–71. Scholar
  100. 100.
    Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol. 2014;4(2):76–81. Scholar
  101. 101.
    Suppli MH, Af Rosenschold PM, Pappot H, Dahl B, Morgen SS, Vogelius IR, Engelholm SA. Stereotactic radiosurgery versus decompressive surgery followed by postoperative radiotherapy for metastatic spinal cord compression (STEREOCORD): Study protocol of a randomized non-inferiority trial. J Radiosurg SBRT. 2016;4(1):S1–9.PubMedPubMedCentralGoogle Scholar
  102. 102.
    Gerszten PC, Burton SA, Ozhasoglu C, McCue KJ, Quinn AE. Radiosurgery for benign intradural spinal tumors. Neurosurgery. 2008;62(4):887–95.; discussion 895-886. Scholar
  103. 103.
    Shin DA, Huh R, Chung SS, Rock J, Ryu S. Stereotactic spine radiosurgery for intradural and intramedullary metastasis. Neurosurg Focus. 2009;27(6):E10. Scholar
  104. 104.
    Monserrate A, Zussman B, Ozpinar A, Niranjan A, Flickinger JC, Gerszten PC. Stereotactic radiosurgery for intradural spine tumors using cone-beam CT image guidance. Neurosurg Focus. 2017;42(1):E11. Scholar
  105. 105.
    Hernandez-Duran S, Hanft S, Komotar RJ, Manzano GR. The role of stereotactic radiosurgery in the treatment of intramedullary spinal cord neoplasms: a systematic literature review. Neurosurg Rev. 2016;39(2):175–83.; discussion 183. Scholar
  106. 106.
    Ryu SI, Kim DH, Chang SD. Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus. 2003;15(5):E10.PubMedGoogle Scholar
  107. 107.
    Lobon MJ, Bautista F, Riet F, Dhermain F, Canale S, Dufour C, Blauwblomme T, Zerah M, Beccaria K, Saint-Rose C, Puget S, Carrie C, Lartigau E, Bondiau PY, Valteau-Couanet D, Grill J, Bolle S. Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey. Springerplus. 2016;5(1):879. Scholar
  108. 108.
    Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, Sayegh ET, Aranda D, Parsa AT. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro-Oncology. 2013;15(2):208–15. Scholar
  109. 109.
    Sgouros S, Malluci CL, Jackowski A. Spinal ependymomas--the value of postoperative radiotherapy for residual disease control. Br J Neurosurg. 1996;10(6):559–66.CrossRefGoogle Scholar
  110. 110.
    Pan J, Ho AL, D'Astous M, Sussman ES, Thompson PA, Tayag AT, Pangilinan L, Soltys SG, Gibbs IC, Chang SD. Image-guided stereotactic radiosurgery for treatment of spinal hemangioblastoma. Neurosurg Focus. 2017;42(1):E12. Scholar
  111. 111.
    Simone CB 2nd, Lonser RR, Ondos J, Oldfield EH, Camphausen K, Simone NL. Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro-Oncology. 2011;13(9):1030–6. Scholar
  112. 112.
    Selch MT, Tenn S, Agazaryan N, Lee SP, Gorgulho A, De Salles AA. Image-guided linear accelerator-based spinal radiosurgery for hemangioblastoma. Surg Neurol Int. 2012;3:73. Scholar
  113. 113.
    Daly ME, Choi CY, Gibbs IC, Adler JR Jr, Chang SD, Lieberson RE, Soltys SG. Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas. Int J Radiat Oncol Biol Phys. 2011;80(1):213–20. Scholar
  114. 114.
    Asthagiri AR, Mehta GU, Zach L, Li X, Butman JA, Camphausen KA, Lonser RR. Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro-Oncology. 2010;12(1):80–6. Scholar
  115. 115.
    Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B, Kirste G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med. 1993;329(21):1531–8. Scholar
  116. 116.
    Pan J, Jabarkheel R, Huang Y, Ho A, Chang SD. Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis. J Neuro-Oncol. 2018;137(1):11–22. Scholar
  117. 117.
    Bridges KJ, Jaboin JJ, Kubicky CD, Than KD. Stereotactic radiosurgery versus surgical resection for spinal hemangioblastoma: A systematic review. Clin Neurol Neurosurg. 2017;154:59–66. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Semmes MurpheyMemphisUSA
  2. 2.Department of NeurosurgeryUniversity of Tennessee Health Science CenterMemphisUSA

Personalised recommendations